Australian study identifies early blood marker for lung cancer risk
A newly identified "blood signature" may predict lung cancer risk more than five years before diagnosis, offering a potential pathway to earlier prevention, a study has revealed.
The findings, published in Cell, could help identify people who would benefit from preventative drugs, even before they receive a lung cancer diagnosis, said a statement from Australia`s Walter and Eliza Hall Institute of Medical Research (WEHI) released Friday.
The study analysed over 48,000 blood samples, identifying a 14-protein signature that predicted lung cancer risk within five years and was validated across eight international datasets, including in non-smokers.
Researchers suggested that the signature does not come from the tumour itself, but reflects an altered inflammatory lung environment that prec...


